ASCO 2012 Lung Cancer Highlights: Dr. Socinski on Continuation Maintenance Alimta in PARAMOUNT Trial


The first of several podcasts we'll be adding here from our ASCO 2012 Lung Cancer Highlights program, co-sponsored with LUNGevity Foundation, is with Dr. Mark Socinski, Professor at the University of Pittsburgh, who discussed the updated results of continuation maintenance therapy with Alimta (pemetrexed) on the PARAMOUNT trial.